Hepatitis C News and Research

Latest Hepatitis C News and Research

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.

10 Aug 2019

Researchers awarded $1.8 million NIH grant to study chronic liver inflammation

A team of researchers at The University of Kansas Cancer Center have been awarded a five-year, $1.8 million grant from the National Institutes of Health to study chronic inflammation of the liver, a major factor in the development of liver cancer.

9 Aug 2019

HistoIndex, ILBS launch Center of Excellence to enhance NASH diagnostics and clinical trials

In a cross border collaboration, HistoIndex and the Institute of Liver & Biliary Sciences (ILBS) in New Delhi, India have jointly launched a Centre of Excellence to aid diagnostics and clinical trials focusing on NASH.

8 Aug 2019

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.

3 Aug 2019

Trump administration ‘open for business’ on drug imports from Canada

A year after calling proposals allowing Americans to import cheaper drugs from Canada a "gimmick," Health and Human Services Secretary Alex Azar said the federal government is "open for business" on such a strategy.

31 Jul 2019

UM researchers receive $14 million from NIH for cutting-edge HIV research

The National Institutes of Health has awarded University of Miami researchers $14 million for an ambitious seven-year project that will keep the Miller School of Medicine at the forefront of cutting-edge HIV research.

30 Jul 2019

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

A new report by the World Health Organization (WHO) shows that 4.5 million deaths could be prevented by 2030, and 26 million beyond that, if 67 countries in the low- and middle-income bracket invest $6 billion a year towards abolishing hepatitis. Hepatitis is a completely preventable and treatable illness at present, and in fact, hepatitis C is completely curable.

29 Jul 2019

Researchers demonstrate positive and negative role of LRH-1 during inflammation

Immune cells prevent bacteria, parasites or viruses from entering the body when, for example, the intestinal epithelium is injured.

26 Jul 2019

People successfully treated for visceral leishmaniasis can still infect others, study confirms

The results of an innovative "infectivity" study conducted by the Drugs for Neglected Diseases initiative and the International Centre for Diarrhoeal Disease Research, Bangladesh confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known as post-kala-azar dermal leishmaniasis.

22 Jul 2019

Researchers identify encephalitis as rare toxicity of immunotherapy treatment

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center investigated why the complication occurred, performing a molecular analysis of the disease's pathology and mining data to determine the incidence of similar occurrences.

22 Jul 2019

Novel vaccine against bee sting allergy successfully tested

A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.

17 Jul 2019

Gut microbiota protects from viral-induced neurologic damage, study finds

Gut microbes produce compounds that prime immune cells to destroy harmful viruses in the brain and nervous system, according to a mouse study published today in eLife.

16 Jul 2019

Homeless people are deprived of primary healthcare services, study finds

A study led by the University of Birmingham has painted a shaming picture of neglect and discrimination shown towards the homeless when accessing UK health services.

16 Jul 2019

Europe reports the highest ever levels of syphilis

A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.

15 Jul 2019

Nanotechnology-based compound used to deliver hepatitis B vaccine

Nanotechnology-based compounds are now being tested as a possible delivery vehicle for vaccines. A team of researchers demonstrated how the oral delivery vehicle SBA-15, one such nanotechnology-based compound can deliver an oral vaccine against hepatitis B to the immune system.

11 Jul 2019